Document is current
Any future updates will be listed below
-
Authors
Dupuy, Pierre https://orcid.org/0000-0002-7451-304X
Boudehen, Yves-Marie https://orcid.org/0000-0003-0021-276X
Faucher, Marion
Buglino, John A
Fay, Allison https://orcid.org/0000-0001-5957-5376
Cantaloube, Sylvain
Grimoire, Yasmina https://orcid.org/0009-0005-0893-4603
Marcoux, Julien
Levet, Florian
Bettarel, Laetitia
Voisin, Bertille
Rech, Jérôme
Bouet, Jean-Yves https://orcid.org/0000-0003-1488-5455
Saurel, Olivier
Sibarita, Jean-Baptiste https://orcid.org/0000-0002-9920-7700
Glickman, Michael
Gutierrez, Claude https://orcid.org/0000-0003-1777-0223
Neyrolles, Olivier https://orcid.org/0000-0003-0047-5885
-
Funding
Funding for this research was provided by:
Fondation pour la Recherche Médicale (EQU202103012733)
Agence Nationale de la Recherche (ANR-21-CE11-0031)
Agence Nationale de la Recherche (ANR-10-INBS-04)
Fondation Bettencourt Schueller (Explore-TB)
European Commission (MTB-DETOX: 101063199)
HHS | NIH | National Institute of Allergy and Infectious Diseases (P30 AI168433)
HHS | NIH | National Institute of Allergy and Infectious Diseases (P30 CA08748)
HHS | NIH | National Institute of Allergy and Infectious Diseases (U19AI135990)
Agence Nationale de Recherches sur le Sida et les Hépatites Virales (ANRS0697b)
- License Information
-
More Information
Article History
Received: 16 May 2025
Revised: 8 January 2026
Accepted: 23 January 2026
First Online: 13 February 2026
Disclosure and competing interests statement
: MSG has received consulting fees from Vedanta Biosciences, PRL NYC and has equity in Vedanta Biosciences. The remaining authors declare no competing interests.
